Our bodies have ten times more microbes than human cells. This set of bacteria is called microbiota. In some instances, bacteria known as pathogens can cause infectious diseases. However, these micro-organisms can also protect ...
Aug 6, 2015
0
199
A phase II clinical trial testing the ability of the generic vaccine bacillus Calmette-Guérin (BCG) to reverse advanced type 1 diabetes has received approval from the U.S. Food and Drug Administration (FDA). The approval ...
Jun 7, 2015
1
470
The genes that increase the risk of Type 1 diabetes have lost their hiding place. A research group that includes a University of Florida genetics expert has located and narrowed down the number of genes that play a role in ...
Mar 9, 2015
0
70
In new research published in Endocrinology, Thomas Burris, Ph.D., chair of pharmacological and physiological science at Saint Louis University, reports that his team has found a way to prevent type I diabetes in an animal ...
Jan 20, 2015
0
14
What is the difference between the treatment of diabetes under an immune scheme compared to the traditional therapy? The patient gets a diagnosis and receives attention, but is also checked for a systemic immune problem and ...
Nov 20, 2014
0
0
The incidence of type 1 childhood diabetes has been increasing rapidly worldwide. If blood sugar levels aren't well-controlled, juvenile diabetes can affect nearly every organ of a child's body. And while long-term complications ...
Oct 3, 2014
0
0
Multiple sclerosis, type 1 diabetes and lupus are autoimmune diseases in which the immune cells can no longer differentiate between friend and foe and thus attack the body's own tissue. Here, the immunoproteasome, which supplies ...
Sep 25, 2014
0
0
(Medical Xpress)—Scientists at the University of Kansas are working toward a potential breakthrough therapy for a host of autoimmune diseases. Long a goal of immunology, the approach targets only the handful of dangerous ...
May 9, 2014
0
0
A combination of genetic predisposition and environmental factors is believed to cause autoimmune (type 1) diabetes. A study published on March 27th in PLOS Pathogens gets at the mechanisms by which rotavirus infection contributes ...
Mar 27, 2014
0
0
Dipeptidyl peptidase-4 inhibitors commonly used to control blood sugar levels in people with type 2 diabetes may also reduce the risk of autoimmune diseases in these patients, according to research presented this week at ...
Oct 30, 2013
0
0
